Aller au contenu principal
Profil bibliographique

Satoshi Kitahara

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

26Publications signalées
138Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Head and Neck Cancer StudiesDental Implant Techniques and OutcomesGastrointestinal disorders and treatmentsBladder and Urothelial Cancer TreatmentsOrthopaedic implants and arthroplasty

Les publications récentes

2017 article OpenAlex

CLINICAL RESULTS OF TOTAL HIP ARTHROPLASTY USING TRIPLE TAPERED SHORT STEM FOR THE PATIENT WITH DYSPLASIA

Yohsuke Harada, Takehiro Miyasaka, Jin Miyagi, Satoshi Kitahara

Introduction Dysplastic hip has not only deficiency of acetabulum but also femoral deformity. Therefore, selection of stem is important in cementless THA for dysplasia. Especially using of short stem should be challenge for deformed femur. We studied clinical performance and radiological findings …

jp (code pays fourni par la source)

0 citations Journal of Bone and Joint Surgery - British Volume
2016 article OpenAlex

THE ACCURACY OF ALIGNMENT IN TOTAL KNEE ARTHROPLASTY USING PATIENT MATCHED INSTRUMENTATION

Satoshi Kitahara, Jin Miyagi, Takehiro Miyasaka, T Kawamoto et autres

Introduction Patient matched instrumentation (PMI) have been proposed the accuracy of bone cuts through custom cutting blocks and provide the proper alignment of total knee arthroplasty (TKA). On the other hand, there are some reports that the introduction of PMI for guiding …

jp (code pays fourni par la source)

0 citations Journal of Bone and Joint Surgery - British Volume
2001 other OpenAlex

[Role of Chemotherapy in head and neck cancer].

Naoyuki Kohno, Satoshi Kitahara

For head and neck cancer, a recent meta-analysis of published randomized trial results showed that concurrent chemoradiotherapy, adjuvant chemotherapy and neoadjuvant chemotherapy may increase absolute survival by 12.1%, 6.5%, and 3.7%, respectively. Initial response rates to first line chemotherapy are high, but …

jp (code pays fourni par la source)

1 citation PubMed
2000 article OpenAlex

The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.

Naoyuki Kohno, Satoshi Kitahara, Etsuyo Tamura, Teruhiko Tanabe et autres

To improve survival rate in advanced head and neck cancer, we scheduled 90 patients to receive low dose cisplatin plus 5-fluorouracil regimen as neoadjuvant(NAC), concurrent(CC), adjuvant(AC), and second line chemotherapy (SC) setting. Our regimen consisted of cisplatin (CDDP 5 mg/m2/1 hr infusion …

jp (code pays fourni par la source)

4 citations PubMed
2000 other OpenAlex

[Chemotherapy for head and neck cancer].

Naoyuki Kohno, Satoshi Kitahara

Chemotherapy for head and neck cancer was initially used as a palliative treatment in advanced and/or recurrent disease. The overall response rate was about 30% but patient survival was sometimes short. It was also observed that complete responders had a significantly longer …

jp (code pays fourni par la source)

1 citation PubMed
Accès ouvert 1997 article OpenAlex

Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma

Ken‐ichiro Yoshida, Shuhei Sumi, K. Arai, Fumitaka Koga et autres

BACKGROUND: Bone scans, widely used for the detection of bone metastases from prostate carcinoma, can neither quantitate metastatic lesions nor detect osteolytic lesions. METHODS: Serum concentrations of the carboxyterminal propeptide of Type I procollagen (PICP), the carboxyterminal pyridinoline cross-linked telopeptide of Type …

jp (code pays fourni par la source)

38 citations Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.